![Douglas Carr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Douglas Carr
Financieel Directeur/CFO bij
CENTURY THERAPEUTICS, INC.
Vermogen: 1 M $ op 31-08-2026
Profiel
Douglas Carr is currently Director at Heritage Conservancy, Chief Financial Officer & Secretary at Century Therapeutics, Inc., and Vice President-Finance at Novira Therapeutics, Inc. Former positions include Business Director-Franchise Division at Zocor Ltd., Controller-Pediatric Vaccines Franchise at Merck & Co., Inc., Financial Controller at Omthera Pharmaceuticals, Inc., and Vice President-Finance & Operations at Century Therapeutics, Inc. Education includes undergraduate studies at Rutgers State University of New Jersey.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 14-09-2026 | 502.907 ( 0,28% ) | 1 M $ | 31-08-2026 |
Actieve functies van Douglas Carr
| Bedrijven | Functie | Begin |
|---|---|---|
| CENTURY THERAPEUTICS, INC. | Financieel Directeur/CFO | 11-07-2025 |
Novira Therapeutics, Inc. | Corporate Officer/Principal | 01-10-2018 |
Heritage Conservancy
 Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Directeur/Bestuurslid | - |
Eerdere bekende functies van Douglas Carr
| Bedrijven | Functie | Einde |
|---|---|---|
Century Therapeutics, Inc. /Old/
 Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Financieel Directeur/CFO | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Zocor Ltd. | Corporate Officer/Principal | - |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Comptroller/Controller/Auditor | - |
Opleiding van Douglas Carr
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Omthera Pharmaceuticals, Inc.
Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zocor Ltd. | |
Heritage Conservancy
Heritage Conservancy Miscellaneous Commercial ServicesCommercial Services Operates as a nonprofit organization for land conservation, historic preservation and community education | Commercial Services |
Century Therapeutics, Inc.
 Century Therapeutics, Inc. BiotechnologyHealth Technology Develops novel allogeneic living drugs for oncology that overcome the limitations of first-generation cell therapies | Health Technology |
Century Therapeutics, Inc. /Old/
Century Therapeutics, Inc. /Old/ BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Novira Therapeutics, Inc. | Electronic Technology |
